Thank you for visiting. EightSpokes completed its journey on Dec 31, 2021.
Enlighten is now a part of Unipr, Inc. Please visit Unipr.com for more info.
Intelligent Cloud-based Solution for Program and Portfolio Management in Life Sciences
Use Cases:
- Pre-Clinical Assays & Early Drug Development Workflows
- Multi-Stage Clinical Development, Site & Study Management
- IND / NDA / BLA / ANDA / 510(K) – Regulatory Filing & Approval
- USA, Top 5 EU, Japan, China, and Global Commercial Launches
- Brand Extensions, Global Supply Chain and Lifecycle Management
- Co-development / Co-commercialization of Products with Partners

 
             
             
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                


 
             
             
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
             
              
              
              
            